Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans.

Article Details

Citation

Liu J, Birzin ET, Chan W, Yang YT, Pai LY, Dasilva C, Hayes EC, Mosley RT, Dininno F, Rohrer SP, Schaeffer JM, Hammond ML

Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans.

Bioorg Med Chem Lett. 2005 Feb 1;15(3):715-8.

PubMed ID
15664843 [ View in PubMed
]
Abstract

The ring oxygen and sulfur analogs of lasofoxifene, 1a and 1b, were synthesized in an attempt to impart ERalpha selectivity, as found in the closely related dihydrobenzoxathiin compound I, recently discovered in these laboratories. The resulting isochroman and isothiochroman compounds were found to exhibit equipotent binding affinities to the ER isoforms and were less active in the inhibition of estradiol-triggered uterine growth when compared to I and lasofoxifene.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
Compound 4-DEstrogen receptor alphaIC 50 (nM)0.8N/AN/ADetails
EstradiolEstrogen receptor alphaIC 50 (nM)1.3N/AN/ADetails
EstradiolEstrogen receptor betaIC 50 (nM)1.1N/AN/ADetails